of AIDS patients need not involve more precautions than those required in the management of hepatitis B infection. The problems facing surgical specialties will be considerable, especially in emergency situations when the AIDS carrier status of patients may well not be known. Psychiatry, too, has to face its own challenges. AIDS patients with severe behavioural disturbance due to mental illness do, of course, at times require physical restraint, which may involve close bodily contact between staff and patient. Hazards for staff then mount, and there should be adequate service provision to deal with all eventualities. Hopefully service planning will anticipate rather than follow events. Each health district should earmark resources to ensure that all healthcare professionals are supported fully in several ways: certainly by provision of facilities, development of a local code of practice for the management of AIDS patients, and good support of junior staff by their seniors. Perhaps most important of all is the knowledge that, provided simple precautions are observed, the risk to health-care staff can be contained within an acceptable level. We will be judged not only by the thoroughness with which we have prepared our services, but also by our ability to remain objective and constructive in our response to the many problems which will be posed by AIDS in the months and years to come. 
Autologous blood transfusion
The safest blood a person can receive is his/her own; donor blood is a foreign protein and is therefore antigenic. Despite this, homologous blood has been freely available to the medical profession since the inception of the National Blood Transfusion Service (NBTS) following the Second World War. The demand for blood and blood components has continued to increase, and has largely been met. However, there have been occasions when the blood supply has been inadequate, sufficient to postpone elective surgery. In addition, the risk of transfusionassociated disease, especially syphilis, malaria, hepatitis arid more recently the human immunodeficiency virus (HIV) 1-3, has brought the whole concept of the 'gift-relationship' under close scrutiny, tempered by emotion, fear and inadequate public knowledge. Some patients have refused transfusion with homologous blood products. The development of an effective blood substitute has not yet materialized. Autologous blood transfusion (ABT) eliminates virtually all the hazards of homologous blood; cross-matching is not required, no disease is transmitted, the presence of drugs is less important .and the risk of isoimmunization to foreign red cell, leukocyte and platelet antigens is excluded. Even patients with religious objections to blood transfusions may accept autotransfusion with certain safeguards.
There is nothing new about ABT, but in the UK the impetus to develop an autologous blood transfusion programme has not been explored to any extent, due to the convenience and availability of blood and blood components from the NBTS. The situation is different in the USA, where autologous transfusion is practised much more widely to make good the deficit in homologous blood supplies. However, the position is changing in this country as the increasing sophistication of surgery indicates that the need for blood has reached a stage when demand is in danger of outstripping the supply. Most elective surgery should be capable of being covered by preoperative blood donation, and there is good evidence that many orthopaedic, vascular and gynaecological procedures can be carried out using autologous blood, particularly as about 25% need no blood at all, and in two-thirds of the operations no homologous blood is required either". The report by James and Smith in this issue (p 284) of the use of ABT in patients undergoing total joint replacement at St Thomas' Hospital, London, provides further confirmation of its safety and efficacy.
There are three methods of collecting blood for autologous transfusion. First, the salvage of blood during or after cardiopulmonary bypass surgery has been practised for many years. Whilst bloodscavenging machines" -7 have not been widely used in the UK, they can also be helpful for patients with ruptured aortic aneurysm and ectopic pregnancy. Coagulation problems may occur, but do not present an insurmountable obstacle. Second, perioperative collection and haemodilution in theatre provides a ready supply of fresh blood for retransfusion at completion of surgery. The third method, preoperative donation and storage":", is cheap and effective, and provides economy of homologous blood usage; it is possible to have as much as 10 units of in-date blood deposited in the blood bank, although such amount would be required only in exceptional circumstances. In the USA, Milles et al. l o established the use of banked autologous blood because it was available, safe and inexpensive, whilst homologous blood was in short supply, costly and carried a high incidence of post-transfusion hepatitis. Other centres have followed their lead, and the preoperative collection of autologous blood for elective surgery has effected considerable saving in the demand for homologous blood. Opponents ofthe method feel that it is difficult to organize, that the patient may become anaemic and that venesection is dangerous. Any patient who is well enough to undergo an elective surgical procedure is medically fit to donate blood preoperatively!". Some would argue that a mild reduction in haematocrit, and therefore blood viscosity, improves the microcirculation and tissue perfusion, and reduces the risk of thromboembolism.
Any hospital setting up an ABT service will need to establish an agreed protocol so that a reliable, effective and safe service is provided for the patient's benefit. Communication is the essence of a successful programme and requires interdisciplinary planning involving the surgeons, anaesthetists and haematologists/blood bank personneI 4 • 8 • 1 z. Surgeons and haematologists will need to identify those operations which will usually require blood, and those only needing a 'type and screen' 13 -1 S instead of a crossmatch, a policy which itself preserves the blood stocks.
The clinician in charge of the patient must ensure that the patient's medical condition will safely permit him to act as his own donor. An advantage will be that the medical fitness of the patient can be assessed long before entry to hospital, and any problems sorted out before the patient is admitted. Obviously, the patient with a severe chronic disease, such as renal failure, is excluded. Patients with cardiac disorders, or even sickle cell anaemia 16, need not necessarily be excluded. Scheduling is all important to ensure that any problems are dealt with, leaving adequate time to collect sufficient blood to cover the expected needs of the particular procedure being carried out.
A patient who is medically eligible for ABT must be fully informed of the requirements and risks of the procedure and should sign a specified consent form for this purpose. In recruiting patients it should be emphasized that ABT is for their own benefit and not a back up for the NBTS. A successful ABT programme will be demanding of all those concerned. A great deal of time will need to be devoted to it, and will require staff dedicated to it. An enthusiastic coordinator is vital to the success of such a programme and perhaps we will see the return, or the establishment, of the hospital blood transfusion officer.
Adequate storage facilities will be necessary, and autologous blood must be kept separate from the homologous blood stock; it must be very clearly identified as being autologous blood, and the patient's notes must indicate that autologous blood is available. On admission to hospital it would be wise for the patient to have a card stating that autologous blood has been collected and is available in the hospital blood bank. If homologous blood is cross-matched for the patient, the autologous units must be used first, and the release of homologous blood should be at the signed request ofthe surgeon or anaesthetist.
ABT is a safe procedure provided that the basic rule of special identification and segregation of the autologous donor unit is followed, and that the units of blood are safely redirected to the person from whom they came 8 • t2 • A separate blood bank record book will be required. The greatest risk of ABT will usually be a clerical error. and the wrong blood given, or the unit becomes infected.
What is the position if the patient does not need a transfusion? Should the blood be returned to the patient? Some would say that we are morally obliged to return it, but this approach can rarely be justified. Can unused blood be used to supplement the blood bank supply? It will be necessary to have the patient's written permission for their blood to be released into the general pool ifit is not needed!". The label on the unit of blood must indicate clearly that the blood is available for general use. Ifpreoperative donor blood is to be so used, testing for syphilis, hepatitis and HIV will be mandatory, not only to protect potential recipients but also to protect staff handling the blood. If the patient is found to be HBsAg or HIV positive, collection of blood for ABT should not proceed. What action occurs at this stage is dependent on the hospital's policy for managing patients with these infections. Under no circumstances is one advocating routine testing for HbsAg and HIV in ABT donors, except for those agreeing to release their blood for general use. Surgical patients are not tested for these infections.
If an ABT donor agrees to make his blood available to the routine blood supply, two important questions must be asked. First, who should determine the donor's blood group and antibody status and screen for disease, and second who collects the blood? The answer to the first is likely to reside with the local Regional Transfusion Centre. It would be technically and legally unacceptable for any other party than the NBTS to test the blood. Also, it is extremely doubtful if the NBTS would accept anyone other than a haematologist or one of their own staff to collect the blood to comply with the rigid conditions they apply to their own blood donors in the interests of patient safety.
How much blood can be collected without causing anaemia in the patient and how often can they be venesected? The rate of blood donation is limited primarily by the donor's ability to regenerate red cells, and will vary between individuals, relating mainly to their circulating blood volume. An average fall of about 4% in packed cell volume (PCV) is likely after each 500 ml venesection 17 and the PCV should not be allowed to fall below 0.35 or the haemoglobin below 11 g/dI 8 • t2 • Availability of iron is frequently a limiting factor on the donor's ability to regenerate red cells, particularly in women. Oral iron therapy, ferrous sulphate BP 200mg twice daily should be given to all autologous donors; parenteral iron therapy is rarely indicated, and carries a higher risk than oral therapy. Patient compliance may limit the effectiveness of iron therapy, but it would be expected that the patient's motivation would provide a sufficient incentive. Bleeding the patient every 72 hours is possible, but where time permits a longer period -perhaps a week -would seem preferable, and there should be a careful evaluation before each donation. Currently the liquid storage capability of blood collected in CPD-adenine permits a 35-day shelf life", and will allow collection of sufficient blood to cater for the great majority of elective surgical procedures.
The technique of 'leap-frogging' is one that allows more intensive collection of donor blood, but it suffers from the drawback of being time-consuming. It involves collecting two units of blood on each occasion and returning one of the earlier collected units at the end of the next phlebotomy session. This ensures that the Hb/PCV is well maintained and an increasing stock of blood is banked. Up to 10 units of in-date blood can be collected by this method, although it is likely to be used infrequently, but adequate notice would be required to collect this much blood. To make maximum use of blood, separation into cells and plasma (frozen) would be valuable.
Should ABT-collected blood be cross-matched? At face value this would appear illogical, but opinions vary on the advisability of doing so. It would seem wise not to change the laboratory routine and depart from the established blood bank practice; it will provide that extra confirmation that the correct blood is being returned to the donor. Meticulous attention to identification and record-keeping, both in the laboratory and in the patient's notes, may make this additional precaution unnecessary; local policy will dictate what is required.
The recent fears of HIV, and the understandable concern of many patients about receiving blood, now prompt a reappraisal ofautologous blood. Besides the fear of HIV transmission, there is a need to consider the effect of homologous blood on the recurrence of colonic cancer, an interesting but unproven claim 1B -2 0 • It seems likely that future blood transfusion practice will make increasing use of this technique, and indeed patients having an elective surgical procedure may insist on it. We should be prepared to meet this demand: it will conserve donor blood for those who need it, particularly the emergency case, and should result in better use of our blood supplies. Nowhere would this be truer than in developing countries, where it is very difficult to obtain an adequate supply of donor blood.
Autologous components will make an important contribution to the blood supply. Total commitment of those involved will be required to establish and maintain an ABT programme, but it is anticipated that the demand and advantages will outweigh the disadvantages. With the introduction of clinical budgeting and the possibility of being charged for the blood we use, ABT may prove to have economic advantages as well". In addition, any autologous transfusion programme must be closely associated with, and complementary to, our well-established NBTS, which will be the organization responsible for maintaining these high standards essential for the safety of all who receive a blood transfusion 3 • 2 1 • The medical profession will need to be educated to provide the safest blood for their patients. It is logical to promote and to proceed with the implementation of an autologous blood transfusion service. Medicinal therapy grows in sophistication continually; the new drugs interfere deeply, subtly and strongly with body systems. This is reflected by the ways in which modern therapy influences and assumes homeostatic controls. They require for their successful use careful monitoring by an informed prescriber. It is reflected also by the increasing and frequent discovery ofdrug actions and effects beyond those for which those drugs were licensed. In such times, it might be expected reasonably that clinical pharmacology, the discipline and the specialty, would grow vigorously. That this is not wholly the case was emphasized at the Anglo-American Workshop on Clinical Pharmacology, held in Airlie, Virginia, in May
